[go: up one dir, main page]

SE8701479L - Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav - Google Patents

Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav

Info

Publication number
SE8701479L
SE8701479L SE8701479A SE8701479A SE8701479L SE 8701479 L SE8701479 L SE 8701479L SE 8701479 A SE8701479 A SE 8701479A SE 8701479 A SE8701479 A SE 8701479A SE 8701479 L SE8701479 L SE 8701479L
Authority
SE
Sweden
Prior art keywords
biologically effective
containing biologically
effective preparations
active substance
biologically active
Prior art date
Application number
SE8701479A
Other languages
Unknown language ( )
English (en)
Other versions
SE8701479D0 (sv
Inventor
U Schroeder
Original Assignee
Carbomatrix Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carbomatrix Ab filed Critical Carbomatrix Ab
Priority to SE8701479A priority Critical patent/SE8701479L/sv
Publication of SE8701479D0 publication Critical patent/SE8701479D0/sv
Priority to PCT/SE1988/000183 priority patent/WO1988007870A1/en
Publication of SE8701479L publication Critical patent/SE8701479L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SE8701479A 1987-04-09 1987-04-09 Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav SE8701479L (sv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE8701479A SE8701479L (sv) 1987-04-09 1987-04-09 Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav
PCT/SE1988/000183 WO1988007870A1 (en) 1987-04-09 1988-04-11 A method for entrapment of biologically active substances and the use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8701479A SE8701479L (sv) 1987-04-09 1987-04-09 Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav

Publications (2)

Publication Number Publication Date
SE8701479D0 SE8701479D0 (sv) 1987-04-09
SE8701479L true SE8701479L (sv) 1988-10-10

Family

ID=20368147

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8701479A SE8701479L (sv) 1987-04-09 1987-04-09 Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav

Country Status (2)

Country Link
SE (1) SE8701479L (sv)
WO (1) WO1988007870A1 (sv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ244147A (en) † 1991-09-03 1994-09-27 Hoechst Ag Echogenic particles which comprise a gas and at least one shaping substance, and their use as diagnostic agents
ATE154241T1 (de) * 1991-10-01 1997-06-15 Takeda Chemical Industries Ltd Mikropartikeln-zusammenfassung zur verlängerten freigabe und herstellung derselbe
AU1702395A (en) * 1994-02-17 1995-09-04 Pankaj Modi Drugs, vaccines and hormones in polylactide coated microspheres
KR100201352B1 (ko) * 1995-03-16 1999-06-15 성재갑 단일주사 백신 제형
SE505146C2 (sv) * 1995-10-19 1997-06-30 Biogram Ab Partiklar för fördröjd frisättning
US5985248A (en) 1996-12-31 1999-11-16 Inhale Therapeutic Systems Processes for spray drying solutions of hydrophobic drugs and compositions thereof
FR2778336A1 (fr) * 1998-05-11 1999-11-12 Jean Pierre Perraud Implant injectable en sous-cutane et en sous-gingival resorbable a base de maltodextrine micro-encapsulee et resorbable en un temps determine
US7575761B2 (en) 2000-06-30 2009-08-18 Novartis Pharma Ag Spray drying process control of drying kinetics
GB0027357D0 (en) 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
JP4837892B2 (ja) 2001-11-01 2011-12-14 ネクター セラピューティクス 粉末バッチを製造する方法
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
US8110674B2 (en) 2003-03-07 2012-02-07 Alnylam Pharmaceuticals, Inc. Therapeutic compositions
EP2660322A3 (en) 2003-04-17 2013-11-13 Alnylam Pharmaceuticals Inc. Modified iRNA agents
EP1625138A4 (en) 2003-04-17 2010-06-23 Alnylam Pharmaceuticals Inc PROTECTED MONOMERS
JP5635412B2 (ja) 2007-12-04 2014-12-03 アルニラム ファーマスーティカルズ インコーポレイテッドＡｌｎｙｌａｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 標的化脂質
EP2274425A2 (en) 2008-04-11 2011-01-19 Alnylam Pharmaceuticals Inc. Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
WO2011109427A2 (en) 2010-03-01 2011-09-09 Alnylam Pharmaceuticals, Inc. Improving the biological activity of sirna through modulation of its thermodynamic profile
CA2767773C (en) 2011-02-11 2015-11-24 Grain Processing Corporation Composition comprising a salt and a crystallization interrupter
WO2016057693A1 (en) 2014-10-10 2016-04-14 Alnylam Pharmaceuticals, Inc. Methods and compositions for inhalation delivery of conjugated oligonucleotide

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE640616A (sv) * 1962-12-19
GB1468172A (en) * 1973-03-28 1977-03-23 Benzon As Alfred Oral drug preparations
US4273920A (en) * 1979-09-12 1981-06-16 Eli Lilly And Company Polymerization process and product
SE8204244L (sv) * 1982-07-09 1984-01-10 Ulf Schroder Kristalliserad kolhydratsmatris for biologiskt aktiva substanser
US4479911A (en) * 1982-01-28 1984-10-30 Sandoz, Inc. Process for preparation of microspheres and modification of release rate of core material
US4530840A (en) * 1982-07-29 1985-07-23 The Stolle Research And Development Corporation Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
FR2557459B1 (fr) * 1984-01-02 1986-05-30 Lhd Lab Hygiene Dietetique Matrice inerte a base de polycaprolactone pour administration orale d'un medicament, et procede de preparation de la forme galenique comprenant cette matrice

Also Published As

Publication number Publication date
WO1988007870A1 (en) 1988-10-20
SE8701479D0 (sv) 1987-04-09

Similar Documents

Publication Publication Date Title
SE8701479L (sv) Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav
ATE68343T1 (de) Darreichungsform mit kontrollierter freigabe.
NO891052D0 (no) Farmaseutisk produkt for styrt avgivelse.
NO904754L (no) Kapsel for innkapsling av biologisk aktive materialer, fremgangsmaate for fremstilling av denne, samt anvendelse derav.
DE3868037D1 (de) Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
DE69013473D1 (de) Cimetidin enthaltende Arzneimittel.
SE8504720L (sv) Ny lekemedelsberedning
HK48392A (en) Drug particles having constant release and immediate release
NO884154D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive preparater.
DK196189D0 (da) Oralt osmotisk dispenseringssystem indeholdende et farmakologisk aktivt stof
NO892826D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat for aa forhindre seksuelt overfoerbare sykdommer.
FR2774288B1 (fr) Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques
DE68928034D1 (de) Protein mit zeitverabreichung
NO882406L (no) Fremgangsmaate for fremstilling av terapeutisk aktive urinstoff- og karbamat-forbindelser.
NO942303D0 (no) Farmasöytisk preparat, samt fremgangsmåte for fremstilling derav
FI891865A7 (sv) Läkemedel som innehåller azelastin med kontrollerad frigöring av det verksamma ämnet
DE68905613D1 (de) Pharmazeutische zubereitung.
FI901290A7 (sv) Förfarande för framställning av ett transdermalt terapeutiskt system med stegvis frigöring av det aktiva ämnet och användning av detta för lokal eller systemisk administrering av det aktiva ämnet
NO921603D0 (no) Fremgangsmaate til fremstilling av et aktivt findelt agregat for bruk til betong
FI880210L (sv) Förfarande för framställning av peroralt stabiliserat, aktivämne retarderat och kontrollerat frigörande, läkemedelspreparat
NO933237D0 (no) Absorbat av en hjelpestoffblanding og et ikke-fast virksomt stoff for fremstilling av legemiddelpreparater
NO904470D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater.
MY103627A (en) A controlled release pharmaceutical dosage form and a process for preparing same.
NO173098C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 10-propynol-androstener
NO891678L (no) Fremgangsmaate for fremstilling av terapeutisk aktive etanolamin-derivater.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8701479-1

Effective date: 19881216